Here, the authors identify gene signatures tied to aggressive prostate cancer predicting poor outcomes. Further, they present data showing that early immune and metabolic shifts in normal-looking glands may signal increased relapse and metastasis risk.
- Sebastian Krossa
- Maria K. Andersen
- May-Britt Tessem
